Elaine Hamm, President of Autigen and CEO of Ascend Bioventures
Tiny Oklahoma company gets the eye of Boehringer Ingelheim, signing deal for regenerative hearing loss treatment
Relative to things like oncology and gene therapy, the field of hearing loss is small in the biotech world. When looking at hearing loss and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
